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NMR Chemistry of Red Blood Cell 
Constituents 
To the Editor: 
Additional comments and corrections need to be 
made to our paper published in this journal (Domino 
et al. 1985). The key metabolite in red blood cells 
is 2,3-diphosphoglycerate and not 2,3 diphospho- 
glycerol, as stated in our paper. Currently 2,3-bis- 
phosphogylcerate is a more acceptable term for this 
key metabolite in red blood cells. As noted in our 
paper, the levels of 2,3-bisphosphogylcerate do not 
change as a result of chronic lithium therapy. 
An additional comment is necessary regarding the 
order of priorities in citing the literature. It should be 
noted that ours was not the first nuclear magnetic 
resonance (NMR) study on this subject. Johnson and 
Kuchel (1980) reported that in 5 1 blood samples of 
patients treated with lithium, there was a correlation 
coefficient of - 0.24 between serum lithium and red 
blood cell choline. Furthermore, red blood cells from 
patients not treated with lithium showed only a minute 
choline resonance in the NMR spectrum. This early 
work was followed by a more detailed NMR study 
by Jones and Kuchel (1980), who showed a dramatic 
increase in red blood cell choline in lithium-treated 
patients. Jones and Kuchel (1980) also assigned cho- 
line to be adjacent to the peak labeled “~4” in the 
NMR paper by Brown et al. (1977), which was pre- 
viously “unassigned, but coincident with quatemary 
amine methyls of acetylcholine”; u4 is now known 
to be ergothioneine (e.g., Kuchel 1981). What we 
reported as their error in assignment was not a true 
error, but rather they noted that the peaks for choline 
and acetylcholine were almost, but not quite, coin- 
cidental. It is well known that red blood cells contain 
acetylcholinesterase and that any acetylcholine pre- 
sent would be rapidly hydrolyzed to choline. Al- 
though the contribution of acetylcholine to the choline 
NMR peak of human red blood cells is certainly neg- 
ligible, there is evidence that minute amounts of ace- 
tylcholine do exist in human red blood cells (see 
Hanin et al. 1978). This latter finding still poses a 
mystery that needs to be solved. 
During the period our paper was being submitted 
for review and publication in this journal, Kuchel et 
al. (1984) reported an extensive study on the deter- 
mination of red blood cell choline and ergothionine 
levels in bipolar patients on lithium maintenance ther- 
apy. After 4 weeks of lithium treatment, red blood 
cell choline levels increased sixfold, whereas ergo- 
thionine levels did not change. The increased choline 
levels were unrelated to clinical state and did not 
distinguish lithium responders from nonresponders. 
Their findings are in agreement with our current opin- 
ion that a potential clinical caveat in measuring red 
blood cell choline in patients is an index of recent 
lithium ingestion if a clinical history is unattainable 
or unreliable. 
Perhaps the most important question is why does 
red blood cell choline increase so dramatically in 
lithium-treated patients. Jenden et al. (1980) pro- 
posed that the choline came from the hydrolysis of 
intracellular phospholipids. Crucial to this proposal 
was evidence by Chapman et al. (1982) that Ca*+- 
dependent phospholipase-D activity is present in hu- 
man red blood cells. Beilharz et al. (1986) have re- 
cently conducted an experimental study and a com- 
puter simulation of the turnover of choline in red 
blood cells of patients treated with lithium. Their 
published answer to this important question involves 
several steps. (1) Plasma phosphatidylcholine, as- 
sociated with high-density lipoproteins, exchanges 
with the phospholipids in the red blood cell mem- 
brane. (2) Phosphatidylcholine in the outer membrane 
undergoes two-dimensional translation and rotation 
and flips between the outer to the inner layer of the 
bilayer. (3) Inner membrane layer phosphatidylcho- 
line is now exposed to intracellular phospholipase D. 
(4) The latter enzyme splits off choline intracellu- 
larly. (5) Free intracellular choline can also come 
from a membrane choline transport system, which 
can transport free choline from the plasma into the 
red blood cell and vice versa. (6) The entire system 
at equilibrium provides a steady-state intracellular red 
blood cell choline level. (7) Choline transport (influx 
as well as efflux) is inhibited by lithium treatment. 
(8) Thus, over time, red blood cell choline accu- 
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mulates to a new steady-state level in the lithium- 
treated patient. 
Perhaps the most important question is whether 
patients treated with lithium show a comparable in- 
crease in their brain choline, as is true in their red 
blood cells. We need to know how lithium exerts its 
remarkable therapeutic effects. Newer techniques, such 
as positron emission tomography (PET) and NMR 
imaging, will hopefully help provide some useful data 
on human brain choline levels that may lead to an 
answer. 
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